Sekeres Previews Potential Combination Strategies in HR-MDS
Season 5, Episode 37, Aug 30, 2021, 08:55 PM
Dr. Sekeres discusses the current unmet needs of patients with higher-risk myelodysplastic syndromes receiving hypomethylating agents, the potential utility of novel combinations in development, and the incorporation of other end points beyond overall survival in clinical trials.